The impact of laronidase treatment in otolaryngological manifestations of patients with mucopolysaccharidosis

The impact of laronidase treatment in otolaryngological manifestations of patients with mucopolysaccharidosis

ABSTRACT INTRODUCTION: Mucopolysaccharidosis (MPS) is a lysosomal storage disease caused by deficiency of a-l-iduronidase. The otolaryngological findings include hearing loss, otorrhea, recurrent otitis, hypertrophy of tonsils and adenoid, recurrent rhinosinusitis, speech disorders, snoring, oral b...

Full description

Bibliographic Details
Main Authors:	Ana Paula Fiuza Funicello Dualibi, Ana Maria Martins, Gustavo Antônio Moreira, Marisa Frasson de Azevedo, Reginaldo Raimundo Fujita, Shirley Shizue Nagata Pignatari
Format:	Article
Language:	English
Published:	Elsevier
Series:	Brazilian Journal of Otorhinolaryngology
Subjects:	Mucopolysaccharidosis I Laronidase Enzymatic replacement therapy URT infections Sleep apnea Hearing loss
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1808-86942016000500522&lng=en&tlng=en

Similar Items

Immune tolerance induction for laronidase treatment in mucopolysaccharidosis I
by: Roberto Giugliani, et al.
Published: (2017-03-01)

EFFICACY AND SAFETY OF ENZYME REPLACEMENT THERAPY IN CHILDREN WITH MUCOPOLYSACCHARIDOSIS TYPE I, II, AND VI: A SINGLE-CENTER COHORT STUDY
by: Liliia A. Osipova, et al.
Published: (2018-04-01)

Enzyme replacement therapy for Mucopolysaccharidosis Type I among patients followed within the MPS Brazil Network
by: Alícia Dorneles Dornelles, et al.
Published: (2014-01-01)

Intravenous Enzyme Replacement Therapy in Mucopolysaccharidoses: Clinical Effectiveness and Limitations
by: Rossella Parini, et al.
Published: (2020-04-01)

The multi-domain responder index: a novel analysis tool to capture a broader assessment of clinical benefit in heterogeneous complex rare diseases
by: P. K. Tandon, et al.
Published: (2021-04-01)

Transcranial pulsed ultrasound facilitates brain uptake of laronidase in enzyme replacement therapy for Mucopolysaccharidosis type I disease
by: Yu-Hone Hsu, et al.
Published: (2017-06-01)

Audiometric evaluation in individuals with mucopolysaccharidosis
by: Marcela Rosana Maia da Silveira, et al.
Published: (2018-12-01)

The importance of the otorhinolaryngologic evaluation in mucopolysaccharidosis patients
by: Bicalho, Cibele Gomes, et al.
Published: (2011-07-01)

Enzyme replacement therapy in Hurler syndrome after failure of hematopoietic transplant
by: Leonor Arranz, et al.
Published: (2015-06-01)

SURGICAL TREATMENT OF CERVICAL STENOSIS IN PATIENTS WITH MUCOPOLYSACCHARIDOSIS: SYSTEMATIC REVIEW
by: S. V. Kolesov, et al.
Published: (2018-07-01)

Alder-Reilly Anomaly in Patients with Mucopolysaccharidosis VI
by: Taiane Alves Vieira, et al.
Published: (2008-09-01)

Audiologic evaluations of children with mucopolysaccharidosis
by: Çağil Gökdoğan, et al.

Mucopolysaccharidosis: MRI Study
by: J Gordon Millichap
Published: (1992-09-01)

Mucopolysaccharidosis type VI: case report with first neonatal presentation with ascites fetalis and rapidly progressive cardiac manifestation
by: Rachel Sayuri Honjo, et al.
Published: (2020-02-01)

Mucopolysaccharidosis Type II in the Practice of the Physician
by: I.Y. Vatanskaya, et al.
Published: (2016-09-01)

Audiologic Evaluation of Patients with Mucopolysaccharidosis at a Pediatric Hospital
by: Gomes, Ariana Braga, et al.
Published: (2011-04-01)

Orthopedic manifestations in patients with mucopolysaccharidosis type II (Hunter syndrome) enrolled in the Hunter Outcome Survey
by: Bianca Link, et al.
Published: (2010-07-01)

POSSIBILITIES OF IMMUNOSTIMULATING THERAPY IN RESPIRATORY INFECTIONS OF UPPER RESPIRATORY TRACTS
by: V. M. Svistushkin, et al.
Published: (2017-05-01)

Hearing Loss in Mucopolysaccharidosis
by: Cibele Gomes Bicalho, et al.
Published: (2021-07-01)

Mucopolysaccharidosis type I Hurler-Scheie syndrome: A rare case report
by: Ramesh Tatapudi, et al.
Published: (2011-01-01)

Proteomic Analysis of Mucopolysaccharidosis IIIB Mouse Brain
by: Valeria De Pasquale, et al.
Published: (2020-02-01)

Evaluation of Demographic and Clinical Characteristics of Patients with Mucopolysaccharidosis
by: Pelin Teke Kısa, et al.
Published: (2017-06-01)

A case of mucopolysaccharidosis type VI in a polish family. Importance of genetic testing and genotype-phenotype relationship in the diagnosis of mucopolysaccharidosis
by: Barbara Zapała, et al.
Published: (2020-12-01)

A case report of a patient with mucopolysaccharidosis type II
by: M.R. Rivera Vega, et al.
Published: (2017-04-01)

Management of Difficult Airway in a Patient with Mucopolysaccharidosis Type II
by: Damla Hanalioğlu, et al.
Published: (2019-08-01)

A rare late progression form of Sly syndrome mucopolysaccharidosis
by: Nathalie Guffon, et al.
Published: (2019-09-01)

The vertebral syndrome in various types of mucopolysaccharidosis: clinical features and treatment
by: Sergey O. Ryabykh, et al.
Published: (2019-06-01)

Atypical presentation of mucopolysaccharidosis type IVA
by: Eric T. Rush
Published: (2016-09-01)

Newborn Screening for Mucopolysaccharidosis Type II in Illinois: An Update
by: Barbara K. Burton, et al.
Published: (2020-09-01)

Assessment of functional capacity of teens who are Mucopolysaccharidosis type II carriers
by: Ingrid Alves Barros Silva Amaral, et al.
Published: (2017-06-01)

Bone metabolism in patients with mucopolysaccharidosis type II
by: Zbigniew Żuber, et al.
Published: (2014-11-01)

Mucopolysaccharidosis Type-II with Pathognomonic Skin Appearance: A Case with Pebbling Sign
by: Ayşe Hitay İnan, et al.
Published: (2021-06-01)

Biomarkers for prediction of skeletal disease progression in mucopolysaccharidosis type I
by: Troy C. Lund, et al.
Published: (2021-03-01)

MODERN APPROACHES TO THERAPY FOR CHILDREN WITH MUCOPOLYSACCHARIDOSIS
by: N. V. Buchinskaya, et al.
Published: (2014-05-01)

Failure to shorten the diagnostic delay in two ultra-orphan diseases (mucopolysaccharidosis types I and III): potential causes and implications
by: Gé-Ann Kuiper, et al.
Published: (2018-01-01)

Pilot study of the safety and effect of adalimumab on pain, physical function, and musculoskeletal disease in mucopolysaccharidosis types I and II
by: Lynda E. Polgreen, et al.
Published: (2017-03-01)

Management of Corneal Clouding in Patients with Mucopolysaccharidosis
by: Orlaith McGrath, et al.
Published: (2021-07-01)

Clinical, radiologic, and genetic features of Korean patients with Mucopolysaccharidosis IVA
by: Na Hee Lee, et al.
Published: (2012-11-01)

Phenotype prediction for mucopolysaccharidosis type I by in silico analysis
by: Li Ou, et al.
Published: (2017-07-01)

The factors affecting lipid profile in adult patients with Mucopolysaccharidosis
by: Karolina M. Stepien, et al.
Published: (2017-09-01)

Cannot write session to /tmp/vufind_sessions/sess_8ofnhja821si3kmkd7hte33l6m